4-Bromo-7-nitro-2,3-dihydro-1H-isoindol-1-one, 97%, 1g

Potassium iodide, min. 99.5%, pa, ISO, 2.5 kg, glass packaging

4-(2,6-Difluoro-phenyl)-3-oxo-butyric acid ethyl ester, 500mg

1-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)piperazine, 95%, 1g

4-Bromo-4'-iodo-1,1'-biphenyl, 95.0%, 1g

3-Fluoro-4-(trifluoromethyl)benzylamine, 97.0%, 1g

2-[3-(DIFLUOROMETHYL)-2-FLUOROPHENYL]-4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLANE, 95%, 10g

trans-trans-Muconic acid, 97%, 1g

3-Methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3H-imidazo[4,5-b]pyridine, 95.0%, 10g

2-(Trifluoromethoxy)phenol, 98.0%, 1g

2-Fluoro-4-iodoaniline, 97.0%, 1g

5,6,7,8-Tetrahydroquinoline>96.0%(GC)(T)10mL

tert-Butyl (R)-(6-oxopiperidin-3-yl)carbamate, 97%, 250mg